Approach to Difficult to Manage Primary Hypertension

Hypertension: A Companion to Braunwald's Heart Disease

Volumn , Issue , 2018, Pages 281-287

  Sorrentino, Matthew J ^a   Bakris, George L ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85042704165     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-42973-3.00030-5     Document Type: Chapter

References (19)

1. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
2. James P.A., Oparil S., Carter B.L., et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014, 311:507-520.
3. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988, 297:319-328.
4. Strom B.L., Anderson C.A., Ix J.H. Sodium reduction in populations: insights from the Institute of Medicine committee. JAMA 2013, 310:31-32.
5. O'Donnell M., Mente A., Rangarajan S., et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med 2014, 371:612-623.
6. Agarwal R., Sinha A.D., Pappas M.K., Ammous F. Chlorthalidone for poorly controlled hypertension in chronic kidney disease: an interventional pilot study. Am J Nephrol 2014, 39:171-182.
7. Madkour H., Gadallah M., Riveline B., Plante G.E., Massry S.G. Indapamide is superior to thiazide in the preservation of renal function in patients with renal insufficiency and systemic hypertension. Am J Cardiol 1996, 77:23B-25B.
8. Ong H.T. Beta blockers in hypertension and cardiovascular disease. BMJ 2007, 334:946-949.
9. Sarafidis P., Bogojevic Z., Basta E., Kirstner E., Bakris G.L. Comparative efficacy of two different beta-blockers on 24-hour blood pressure control. J Clin Hypertens (Greenwich) 2008, 10:112-118.
10. Figueredo V.M. The time has come for physicians to take notice: the impact of psychosocial stressors on the heart. Am J Med 2009, 122:704-712.
11. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004, 89:2548-2556.
12. Alderman M.H., Cohen H.W., Sealey J.E., Laragh J.H. Plasma renin activity levels in hypertensive persons: their wide range and lack of suppression in diabetic and in most elderly patients. Am J Hypertens 2004, 17:1-7.
13. Elliott W.J., Meyer P.M. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007, 369:201-207.
14. Chapman N., Dobson J., Wilson S., et al. Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension 2007, 49:839-845.
15. Williams B., MacDonald T.M., Morant S., et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet 2015, 386:2059-2068.
16. Lazich I., Bakris G.L. Prediction and management of hyperkalemia across the spectrum of chronic kidney disease. Semin Nephrol 2014, 34:333-339.
17. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913.
18. Cushman W.C., Evans G.W., Byington R.P., et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010, 362:1575-1585.
19. Wright J.T., Williamson J.D., Whelton P.K., et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015, 373:2103-2116.